Top

Published in:

01-05-2016 | Original Paper

Late Diagnosis of HIV Infection in Metropolitan Areas of the United States and Puerto Rico

Authors: H. Irene Hall, Tian Tang, Lorena Espinoza

Published in: AIDS and Behavior | Issue 5/2016

Abstract

The majority of persons infected with HIV live in large metropolitan areas and many such areas have implemented intensified HIV testing programs. A national indicator of HIV testing outcomes is late diagnosis of HIV infection (stage 3, AIDS). Based on National HIV Surveillance System data, 23.3 % of persons with HIV diagnosed in 2012 had a late diagnosis in large MSAs, 26.3 % in smaller MSAs, and 29.6 % in non-metropolitan areas. In the 105 large MSAs, the percentage diagnosed late ranged from 13.2 to 47.4 %. During 2003–2012, the percentage diagnosed late decreased in large MSAs (32.2–23.3 %), with significant decreases in 41 of 105 MSAs overall and among men who have sex with men. Sustained testing efforts may help to continue the decreasing trend in late-stage HIV diagnosis and provide opportunities for early care and treatment and potential reduction in HIV transmission.

Available only for authorised users

Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. 2006;55(9):1–17.PubMed

Moyer VA. U.S. preventive services task force. screening for HIV: U.S. Preventive services task force recommendation statement. Ann Intern Med. 2013;159(1):51–60.PubMed

Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. May 1, 2014:D1-E47. Available at: http://www.aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf.

Centers for Disease Control and Prevention. Expanded testing program—overview. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; August 2011.

Centers for Disease Control and Prevention. High-impact HIV prevention: CDC’s approach to reducing HIV infections in the United States. Available at: http://www.cdc.gov/hiv/policies/hip.html. Accessed March 17, 2015.

Health Resources and Services Administration. HRSA care action: high-impact prevention. Available at: http://hab.hrsa.gov/deliverhivaidscare/files/high_impact_prevention.pdf. Accessed March 17, 2015.

Hutchinson AB, Farnham PG, Duffy N, et al. Return on public health investment: CDC’s expanded HIV testing initiative. J Acquir Immune Defic Syndr. 2012;59(3):281–6.CrossRefPubMed

Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. NEJM. 2011;365(6):493–505.CrossRefPubMedPubMedCentral

Centers for Disease Control and Prevention. HIV testing trends in the United States, 2000–2011. Atlanta, GA: U.S. Department of Health and Human Services, January 2013:1–35. Available at: http://www.cdc.gov/hiv/pdf/testing_trends.pdf. Accessed March 17, 2015.

10.

Cooley LA, Oster AM, Rose CE, et al. Increases in HIV testing among men who have sex with men—national HIV behavioral surveillance system, 20 U.S. metropolitan statistical areas, 2008 and 2011. PLoS ONE. 2014;9(9):e104162. doi:10.1371/journal.pone.0104162.CrossRefPubMedPubMedCentral

11.

Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas—2012. HIV Surveillance Supplemental Report 2014;19(3). http://www.cdc.gov/hiv/library/reports/surveillance/. Published November 2014. Accessed February 4, 2015.

12.

Centers for Disease Control and Prevention. HIV surveillance report, 2013; 25:76. Available at: http://www.cdc.gov/hiv/library/reports/surveillance/. Published February 2015. Accessed May 17, 2015.

13.

Valdiserri RO, Forsyth AD, Yakovchenko V, Koh HK. Measuring what matters: development of standard HIV core indicators across the U.S. Department of Health and Human Services. Public Health Rep. 2013;128(5):354–9.PubMedPubMedCentral

14.

U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Healthy People 2020 Objectives. HIV-9 Reduce the proportion of persons with a diagnosis of Stage 3 HIV (AIDS) within 3 months of diagnosis of HIV infection. Available at: https://www.healthypeople.gov/2020/topics-objectives/topic/hiv/objectives. Accessed March 17, 2015.

15.

Selik RM, Mokotoff ED, Branson B, Owen SM, Whitmore S, Hall HI. Revised surveillance case definition for HIV infection—United States, 2014. MMWR. 2014;63(RR03):1–10.

16.

Office of Management and Budget. Revised definitions of metropolitan statistical areas, new definitions of micropolitan statistical areas and combined statistical areas, and guidance on uses of the delineations of these areas. OMB Bulletin 13-01. http://go.usa.gov/vSyB. Published February 28, 2013. Accessed December 1, 2014.

17.

McDavid Harrison K, Kajese T, Hall HI, Song R. Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach. Public Health Rep. 2008;123(5):618–27.

18.

Hall HI, Song R, Szwarcwald CL, Green T. Time from infection with the human immunodeficiency virus to diagnosis, United States. J Acquir Immune Defic Syndr. 2015;6992:248–51.

19.

Lesko CR, Cole SR, Zinski A, Poole C, Mugavero MJ. A Systematic review and meta-regression of temporal trends in adult CD4+ cell count at presentation to HIV care, 1992–2011. Clin Infect Dis. 2013;57(7):1027–37.CrossRefPubMed

20.

Gray KM, Branson B, Donnell DJ, Beauchamp G, Hu X, Wang Z, El Sadr W, Hall HI. HIV testing in six US cities using behavioral surveillance data for the TLC-Plus (HPTN 065) study. XIX International AIDS Conference. Washington, 2012 [abstract TUPE 293].

21.

Centers for Disease Control and Prevention. Results of the expanded HIV testing initiative—25 Jurisdictions, United States, 2007–2010. MMWR. 2011;60(24):805–10.

22.

Cooley LA, Wejnert C, Rose CE, Paz-Bailey G, National HIV. Behavioral surveillance study group. Increases in recent HIV testing among men who have sex with men coincide with the centers for disease control and prevention’s expanded testing initiative. Clin Infect Dis. 2015;60(3):483–5.CrossRefPubMedPubMedCentral

23.

Burns DN, DeGruttola V, Pilcher CD, et al. Toward an endgame: finding and engaging people unaware of their HIV-1 infection in treatment and prevention. AIDS Res Hum Retrovir. 2014;30(4):217–24.CrossRefPubMedPubMedCentral

24.

Xia Q, Kobrak P, Wiewel EW, Torian LV. The high proportion of late HIV diagnoses in the USA is likely to stay: findings from a mathematical model. AIDS Care. 2015;27(2):206–12.CrossRefPubMed

25.

Xia Q, Torian LV, Shepard CW. Limitations of Indicators of HIV case Finding. Epidemiology. 2015;26(1):e6–8.CrossRefPubMed

26.

Hayek S; Dietz PM, Van Handel M, et al. Centers for Disease Control and Prevention funding for HIV testing associated with higher state percentage of persons tested. J Public Health Manag Pract. 2015 Feb 12. [Epub ahead of print].

Title: Late Diagnosis of HIV Infection in Metropolitan Areas of the United States and Puerto Rico
Authors: H. Irene Hall
Tian Tang
Lorena Espinoza
Publication date: 01-05-2016
Publisher: Springer US
Published in: AIDS and Behavior / Issue 5/2016
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-015-1241-5

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Late Diagnosis of HIV Infection in Metropolitan Areas of the United States and Puerto Rico

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2016

Navigating Barriers to Vocational Rehabilitation for HIV-Positive Persons

Structural Barriers to Antiretroviral Therapy Among Sex Workers Living with HIV: Findings of a Longitudinal Study in Vancouver, Canada

Retention in Early Care at an HIV Outpatient Clinic in Rio de Janeiro, Brazil, 2000–2013

A Randomized Controlled Trial of Personalized Text Message Reminders to Promote Medication Adherence Among HIV-Positive Adolescents and Young Adults

Antiretroviral Refill Adherence Correlates with, But Poorly Predicts Retention in HIV Care

Which Clinician Questions Elicit Accurate Disclosure of Antiretroviral Non-adherence When Talking to Patients?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page